Sertbas Meltem, Guduk Ozlem, Guduk Ozden, Yazici Zeynep, Dagci Selma, Sertbas Yasar
Department of Internal Medicine, Health Sciences University Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey.
Health Institutes of Turkey, Istanbul, Turkey.
North Clin Istanb. 2019 Oct 25;7(2):140-145. doi: 10.14744/nci.2019.59751. eCollection 2020.
Diabetes is one of the primary diagnoses for admission to home health care units. Although there are many studies about elderly diabetic patients, there are not many studies on home care patients with diabetes. The present study aims to analyze the current status of diabetic home care patients with their biochemical data and medications.
This was a retrospective study, including 256 diabetic patients who were following up by the Home Health Unit of Istanbul Provincial Health Directorate Public Hospitals Services-2. In this study, we analyzed the current biochemical data of the patients with their medications.
In this study, 185 female (72.3%) and 71 male (27.7%) patients were recruited with the mean HbA1c of 8.25±1.77. Among these patients, 65% of them were using oral antidiabetic (OAD), and 58% were using insulin. There were 21 (8.2%) patients who were not receiving any treatment. While patients who were using only oral antidiabetic have better A1c levels (A1c: 7.73±1.45), patients who were insülin using had HbA1c levels as high as the patients who were not using any medication. This may be due to the progression of diabetes, fear of hypoglycemia or insufficient insülin use. While metformin was the most commonly used OAD, with a 38% usage rate. When compared to HbA1c levels, there was no difference between the types of insulin used (p=0.167).
As a result, it is important to plan regular visits and personalized treatment by keeping in mind the benefits to risk ratios in home-care diabetic patients.
糖尿病是家庭保健单位收治患者的主要诊断之一。尽管有许多关于老年糖尿病患者的研究,但针对接受家庭护理的糖尿病患者的研究并不多。本研究旨在通过生化数据和用药情况分析糖尿病家庭护理患者的现状。
这是一项回顾性研究,纳入了伊斯坦布尔省卫生局公立医院服务-2家庭保健单位随访的256例糖尿病患者。在本研究中,我们分析了患者的当前生化数据及其用药情况。
本研究共纳入185例女性患者(72.3%)和71例男性患者(27.7%),平均糖化血红蛋白(HbA1c)为8.25±1.77。在这些患者中,65%使用口服降糖药(OAD),58%使用胰岛素。有21例(8.2%)患者未接受任何治疗。仅使用口服降糖药的患者糖化血红蛋白水平较好(糖化血红蛋白:7.73±1.45),而使用胰岛素的患者糖化血红蛋白水平与未使用任何药物的患者一样高。这可能是由于糖尿病病情进展、对低血糖的恐惧或胰岛素使用不足所致。二甲双胍是最常用的口服降糖药,使用率为38%。与糖化血红蛋白水平相比,所用胰岛素类型之间无差异(p=0.167)。
因此,在家庭护理糖尿病患者时,牢记风险效益比来规划定期访视和个性化治疗非常重要。